Article Information
History
- March 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Daniel Wrapp1,#,
- Dorien De Vlieger2,3,4,#,
- Kizzmekia S. Corbett5,
- Gretel M. Torres6,
- Wander Van Breedam2,3,
- Kenny Roose2,3,
- Loes van Schie2,3,
- VIB-CMB COVID-19 Response Team,
- Markus Hoffmann7,
- Stefan Pöhlmann7,8,
- Barney S. Graham5,
- Nico Callewaert2,3,
- Bert Schepens2,3,4,*,
- Xavier Saelens2,3,4,* and
- Jason S. McLellan1,*
- 1Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA 78712
- 2VIB Center for Medical Biotechnology, VIB, 9052 Ghent, Belgium
- 3Department of Biochemistry and Microbiology, Ghent University, 9052 Ghent, Belgium
- 4Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium
- 5Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA 20892
- 6Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA 03756
- 7Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, 37077 Göttingen, Germany
- 8Faculty of Biology and Psychology, University Göttingen, 37077 Göttingen, Germany
- ↵*Correspondence: bert.schepens{at}vib-ugent.be (B.S.), xavier.saelens{at}vib-ugent.be (X.S.), jmclellan{at}austin.utexas.edu (J.S.M.)
↵# These authors contributed equally to this work